Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis

Objective To quantify comparative effectiveness of interleukin (IL)−12/23 antagonist (ustekinumab), IL-17A antagonists (secukinumab and ixekizumab), PDE4 inhibitor (apremilast) and tumour necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab)...

Full description

Bibliographic Details

Published in:	RMD Open
Main Authors:	Jeffrey R Curtis, G Caleb Alexander, Jiajun Wen, Hanzhe Zhang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-03-01
Online Access:	https://rmdopen.bmj.com/content/7/1/e001399.full